Active surveillance for early prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study compares two ways of managing early-stage prostate cancer: active surveillance (regular monitoring) and surgery to remove the prostate. It aims to see which approach is better for men with low or intermediate risk prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a man aged 45 or older.
- You must have been diagnosed with prostate cancer within the last 18 months.
- Your cancer must be Grade Group 1 (with a visible MRI lesion) or Grade Group 2.
- You must be a candidate for active surveillance (monitoring without immediate treatment).
- Your PSA level must be less than 15, and your prostate must be at least 25 ml in size.
- You must not have had any prior treatment for prostate cancer (surgery, radiation, hormone therapy, etc.).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a “watchful waiting” approach, where doctors closely monitor certain prostate cancers with regular checkups and repeat biopsies. It may help people avoid or delay treatment side effects while watching for signs the cancer needs treatment.
This study follows men with low-risk prostate cancer who choose active surveillance (watching closely instead of immediate treatment). It aims to better track which monitoring results stay reassuring over time, and when treatment might be needed.
This is a registry study that follows men with low-risk prostate cancer who choose active surveillance instead of immediate treatment. It helps doctors understand how safe and effective active surveillance is, including confirming results with repeat biopsies.
This trial studies whether men with low-risk prostate cancer can safely avoid treatment by closely monitoring their cancer over many years. It tests a new approach to see if it is better than the current standard of care.
This trial follows men with prostate cancer who choose “active surveillance” instead of immediate treatment. It tests whether careful tracking (including patient reports) can help manage cancer over time and guide decision-making.
This study follows people with early-stage prostate cancer who choose active surveillance instead of immediate treatment. It aims to see how monitoring with repeat prostate biopsies and follow-up works over time.
Hear when a new Localized Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.